CN115814001A - 一种速愈治疗皮肤病的中药外用喷剂 - Google Patents
一种速愈治疗皮肤病的中药外用喷剂 Download PDFInfo
- Publication number
- CN115814001A CN115814001A CN202310014845.5A CN202310014845A CN115814001A CN 115814001 A CN115814001 A CN 115814001A CN 202310014845 A CN202310014845 A CN 202310014845A CN 115814001 A CN115814001 A CN 115814001A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- spray
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000017520 skin disease Diseases 0.000 title claims abstract description 42
- 239000007921 spray Substances 0.000 title claims abstract description 40
- 230000000699 topical effect Effects 0.000 title claims description 6
- 239000003814 drug Substances 0.000 claims abstract description 135
- 238000000855 fermentation Methods 0.000 claims abstract description 63
- 230000004151 fermentation Effects 0.000 claims abstract description 63
- 239000011669 selenium Substances 0.000 claims abstract description 21
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 20
- 241000332747 Dysosma versipellis Species 0.000 claims abstract description 18
- 240000007849 Macleaya cordata Species 0.000 claims abstract description 18
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 18
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 18
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 17
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 16
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 16
- 239000004863 Frankincense Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 240000005959 Abelmoschus manihot Species 0.000 claims abstract description 15
- 235000001075 Abelmoschus manihot Nutrition 0.000 claims abstract description 15
- 240000004760 Pimpinella anisum Species 0.000 claims abstract description 15
- 235000012550 Pimpinella anisum Nutrition 0.000 claims abstract description 15
- 235000019510 Long pepper Nutrition 0.000 claims abstract description 14
- 240000003455 Piper longum Species 0.000 claims abstract description 14
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 230000035876 healing Effects 0.000 claims abstract description 7
- 230000001580 bacterial effect Effects 0.000 claims abstract description 5
- 230000003612 virological effect Effects 0.000 claims abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 239000000243 solution Substances 0.000 claims description 46
- 241000894006 Bacteria Species 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000000813 microbial effect Effects 0.000 claims description 15
- 238000002386 leaching Methods 0.000 claims description 14
- 241000208422 Rhododendron Species 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 244000052769 pathogen Species 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000589220 Acetobacter Species 0.000 claims description 3
- 241000186361 Actinobacteria <class> Species 0.000 claims description 3
- 241000589151 Azotobacter Species 0.000 claims description 3
- 241000186000 Bifidobacterium Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 241000108664 Nitrobacteria Species 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 241000223259 Trichoderma Species 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 230000000243 photosynthetic effect Effects 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 2
- 230000010355 oscillation Effects 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 208000002193 Pain Diseases 0.000 abstract description 16
- 208000003251 Pruritus Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 230000004054 inflammatory process Effects 0.000 abstract description 9
- 230000007803 itching Effects 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000002588 toxic effect Effects 0.000 abstract description 9
- 208000015898 Bacterial Skin disease Diseases 0.000 abstract description 6
- 208000012544 Viral Skin disease Diseases 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 208000007163 Dermatomycoses Diseases 0.000 abstract description 5
- 206010012504 Dermatophytosis Diseases 0.000 abstract description 5
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 238000005507 spraying Methods 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 230000017423 tissue regeneration Effects 0.000 abstract description 2
- 240000006053 Garcinia mangostana Species 0.000 abstract 1
- 235000017048 Garcinia mangostana Nutrition 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 235000011649 selenium Nutrition 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 210000002683 foot Anatomy 0.000 description 13
- 241001122767 Theaceae Species 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- -1 flavone glycoside Chemical class 0.000 description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 210000003371 toe Anatomy 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 5
- 206010017711 Gangrene Diseases 0.000 description 5
- 208000007514 Herpes zoster Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 235000008777 kaempferol Nutrition 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 4
- 241000700198 Cavia Species 0.000 description 4
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 229960004150 aciclovir Drugs 0.000 description 4
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 240000007232 Illicium verum Species 0.000 description 3
- 235000008227 Illicium verum Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 210000001255 hallux Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 3
- 229960001237 podophyllotoxin Drugs 0.000 description 3
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 206010016936 Folliculitis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 2
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 description 2
- LLEJIEBFSOEYIV-UHFFFAOYSA-N chelerythrine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000002068 microbial inoculum Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 229940084560 sanguinarine Drugs 0.000 description 2
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- KKOXKGNSUHTUBV-CABCVRRESA-N (+)-zingiberene Chemical compound CC(C)=CCC[C@@H](C)[C@@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-CABCVRRESA-N 0.000 description 1
- KKOXKGNSUHTUBV-GJZGRUSLSA-N (-)-Zingiberene Natural products [C@@H](CC/C=C(\C)/C)(C)[C@H]1C=CC(C)=CC1 KKOXKGNSUHTUBV-GJZGRUSLSA-N 0.000 description 1
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 1
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 1
- 206010049927 Dry gangrene Diseases 0.000 description 1
- 241000893563 Dysosma Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 description 1
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 244000083724 Rhododendron simsii Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000758724 Schisandraceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010090932 Vitellogenins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HYBRYAPKQCZIAE-UHFFFAOYSA-N allocryptopine Chemical compound C1=C2CCN(C)CC3=C(OC)C(OC)=CC=C3CC(=O)C2=CC2=C1OCO2 HYBRYAPKQCZIAE-UHFFFAOYSA-N 0.000 description 1
- NGFLTEGALWMQIJ-UHFFFAOYSA-N allocryptopine Natural products COc1ccc2CC(=O)c3cc4OCOc4cc3CN(C)CCc2c1OC NGFLTEGALWMQIJ-UHFFFAOYSA-N 0.000 description 1
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 description 1
- HUIJAZQRYSCNED-UHFFFAOYSA-N alpha-allo-cryptopine Natural products C1CN(C)CC2=C(OC)C(OC)=CC=C2CC(=O)C2=CC(OC)=C(OC)C=C21 HUIJAZQRYSCNED-UHFFFAOYSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- OFTGWWXCYHSXPO-UHFFFAOYSA-N alpha-zingiberene Natural products CC(CCC=C(C)C)C1C=CC(C)C=C1 OFTGWWXCYHSXPO-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- XZRVRYFILCSYSP-UHFFFAOYSA-N beta-Bisabolene Natural products CC(C)=CCCC(=C)C1CCC(C)=CC1 XZRVRYFILCSYSP-UHFFFAOYSA-N 0.000 description 1
- FSRZGYRCMPZNJF-UHFFFAOYSA-N beta-Cubebene Natural products C12C(C(C)C)CCC(C)C32C1C(=C)CC3 FSRZGYRCMPZNJF-UHFFFAOYSA-N 0.000 description 1
- FSRZGYRCMPZNJF-KHMAMNHCSA-N beta-cubebene Chemical compound CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(=C)CC3 FSRZGYRCMPZNJF-KHMAMNHCSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical group 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- RSYBQKUNBFFNDO-UHFFFAOYSA-N caryophyllene oxide Natural products CC1(C)CC2C(=C)CCC3OC3(C)CCC12C RSYBQKUNBFFNDO-UHFFFAOYSA-N 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000003929 dermatomycosis Diseases 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960001660 histamine phosphate Drugs 0.000 description 1
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 229930013397 isoquinoline alkaloid Natural products 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000008588 molluscum contagiosum Diseases 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 125000001474 phenylpropanoid group Chemical group 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 201000000508 pityriasis versicolor Diseases 0.000 description 1
- 201000004303 plantar wart Diseases 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 210000001698 popliteal fossa Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- VSLFLWQBWGEPBW-UHFFFAOYSA-N tetrahydropiperic acid Natural products OC(=O)CCCCC1=CC=C2OCOC2=C1 VSLFLWQBWGEPBW-UHFFFAOYSA-N 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- JFJZZMVDLULRGK-URLMMPGGSA-O tubocurarine Chemical compound C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CCN3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 JFJZZMVDLULRGK-URLMMPGGSA-O 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种中药发酵液外用喷剂用于皮肤病的速愈治疗,其所用原料药包括博落回、黄蜀葵、荜茇、八角莲、乳香、丁香、满山香、大茴香和富硒茶叶;其功效是消疼止痒、杀菌消炎、噬菌清洁、清热解毒、活血生肌、增强免疫、促进愈合;对于病毒性、细菌性和真菌性皮肤病的治疗,具有广泛的起效快、疗效高,痊愈率高,不易复发,病灶喷涂刺激小,无不良反应和毒副作用的特点。
Description
技术领域
本发明涉及一种速愈治疗皮肤病的中药外用喷剂,特别是涉及针对病原体感染引起病毒性皮肤病、细菌性皮肤病或真菌性皮肤病速愈治疗的中药发酵液喷剂,所述中药发酵液是由中药组合物经溶剂浸取制得浸取液,所述浸取液再经发酵而成。
背景技术
人体皮肤在遭遇机械、物理、光、射线、化学或生物等内外因素的刺激时,都可使皮肤受到损害进而发生皮肤病。如环境中的病原体侵入人体皮肤引发肤病,主要类型有①病毒性皮肤病,常见有单纯疱疹、带状疱疹、疣(包括寻常疣、跖疣、扁平疣、传染性软疣、尖锐湿疣)、水痘、风疹、手足口病;②细菌性皮肤病,常见的有脓疱病、毛囊炎、疖、痈、蜂窝织炎、丹毒及麻风;③真菌性皮肤病,常见有头癣、体股癣、手足癣、甲真菌病、花斑糠疹、马拉色菌毛囊炎。
治疗病原体引起皮肤病的方法有很多,比如西医内服抗生素药物、抗病毒药物、抗过敏药物等,外用抗生素软膏、抗病毒软膏、抗真菌软膏、消炎类软膏等。西医治疗皮肤病见效快,但难以根治。皮肤病的西医治疗也由此带来一些副作用,比如过多使用抗生素,也会引起身体免疫的耐药性,破坏机体的防卫系统和抑制免疫反应能力。使用含激素类药物后引起痤疮、损害肠胃肾脏功能等,并对激素产生了的依赖性,特别是婴儿或儿童等人群对此类药物更应慎用。病原体引起皮肤病多种多样,治疗难度大,由于皮肤病又易受到一些诱因反复发作,断根治疗难,也给患者带来沉重的经济负担。
中医认为人体内湿气、火气、热气、痰浊等毒素积累过多,肝肾排毒不畅,就通过病原体引起皮肤病变的方式向体外排出,造成了各种各样的病原体诱因皮肤病。中医治疗倡导通过整体调节人体平衡来遵循整体观,达到阴平阳秘。通过辨病与辨证相结合、局部辨证和全身辨证相结合、内治与外治相结合、对症用药、局部用药以及辨病用药相结合的原则,从而使人体达到一种平衡状态。现今已有许多关于治疗病原体引发皮肤病的外用中药,例如ZL200510010845.X、ZL200510003033.2、ZL201210247422.X、ZL200910158291.6、CN201510610256.9、CN201410675132.4、CN201610528134.X、CN201810025055.6等等。传统中药显示出中药外用制剂对治疗皮肤病的特别功效。但中药外用制剂的中药原料药组合物及其制剂方法不同,治疗病原体引起皮肤病的侧重点、药效和治愈快慢也不同。
发明内容
本发明提供一种速愈治疗皮肤病的中药外用喷剂,其特别涉及用于制备所述中药外用喷剂的所用原料药是按照下述重量份数组成:博落回6~12份、黄蜀葵6~12份、荜茇6~12份、八角莲6~12份、乳香2~12份、满山香2~8份、丁香2~8份、大茴香2~8份和富硒茶叶12~60份,所述皮肤病指的是由病原体引起的病毒性皮肤病、细菌性皮肤病或真菌性皮肤病。实现本发明的具体方案如下所述步骤:
步骤一、中药浸取液的制备
按照所述原料药重量份数称取,后一起混合研磨粉碎,过20~80目筛,制得中药组合物粉末;按重量比为1:0.5~50的比例,将所述中药组合物粉末浸没于乙醇水溶液中,控温10~60℃浸泡1~7天后,过滤弃渣,制得中药浸取液,或经浓缩制得中药浸取浓缩液,备用;
其中所述中药组合物粉末和乙醇水溶液重量比为1:5~15;
所述原料药包括:博落回6~12克、黄蜀葵6~12克、荜茇6~12克、八角莲6~12克、乳香2~12克、满山香2~8克、丁香2~8克、大茴香2~8克和富硒茶叶12~60克;
优选的所述原料药包括:博落回12克、黄蜀葵12克、荜茇12克、八角莲12克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶叶40克;
优选的所述原料药包括:博落回6克、黄蜀葵6克、荜茇12克、八角莲12克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶叶20克;
优选的所述原料药包括:博落回12克、黄蜀葵12克、荜茇6克、八角莲6克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶叶20克;
优选的所述原料药包括:满山香8克、八角莲8克、博落回6克、黄蜀葵6克、荜茇6克、乳香6克、丁香2克、大茴香4克和富硒茶叶40克。
依据现代中药浸取技术,本发明人筛选了中药组合物粉末的浸取溶剂,所述浸取溶剂指的是水、甲醇、乙醇、丙酮、丁酮或乙酸乙酯中的一种或两种以上;其中本发明研究结果显示所述原料药的有效成分萃取率高、工艺过程简单、安全有效的浸取溶剂是乙醇体积分数为50~95%的乙醇水溶液,优选乙醇体积分数为75~93%的乙醇水溶液作为所述中药组合物浸取用溶剂。
如上所述,其中博落回性温,味辛、苦,有大毒。博落回的主要生物活性物质包括异喹啉类生物碱,如血根碱、白屈菜红碱、原阿片碱、别隐品碱等,具有抗微生物、杀虫、抗病毒、抗炎、抗肿瘤、改善肝脏功能、增强免疫力等多种生物学活性。博落回具有清热解毒、消肿止痛、燥湿止带、杀虫止痒的功效。一些药理研究表明,博落回对多种炎症治疗有效,对蝇蛆有杀灭作用,对T淋巴细胞和B淋巴细胞功能均有刺激作用,能够较好增强免疫功能。另外血根碱能显著抑制胰腺癌细胞或人肝癌细胞的生长、增殖、发育,对菌落形成的抑制能力强,对肝癌细胞具有明显的杀伤作用。
黄蜀葵性凉、味甘,化学分析其中主要含有黄酮及黄酮苷类的树皮素-3-洋槐糖甙,槲皮素-3-葡萄糖甙,金丝桃甙,杨梅素及槲皮素等。黄蜀葵具有清热祛湿,消肿利尿,清热解毒的功效。药理实验证明大量黄酮及黄酮苷类具有抗炎、镇痛、抗癌作用,能抗氧化,清除体内的自由基,清除肾脏部位的垃圾与毒素,有保肝护肝的作用,促进毒素排出。
荜茇味辛、性热,含有胡椒碱、棕榈酸、四氢胡椒酸、十一碳-1-烯-3,4-甲撑二氧苯、胡椒酰胺、双异桉脂素等类成分。其中挥发油中含有β-甜没药烯、十三烷、石竹烯、β-芹子烯、β-荜澄茄油烯、α-姜烯、十五烷、α-葎草烯等,药理表明其具有显著抗溃疡,其挥发油对金黄色葡萄球菌、枯草杆菌、蜡样芽胞杆菌、结核杆菌、痢疾杆菌、伤寒沙门氏菌T和B、卵黄色八叠菌等和流感病毒均有抑制作用。
八角莲性凉,味苦、辛,有毒。八角莲的生物活性成分有木脂素类化合物、黄酮类化合物、生物碱和甾醇类化合物。其中药用活性物主要是鬼臼毒素及其衍生物、山荷叶素、鬼臼毒酮及其糖苷、八角莲醇、山柰酚、槲皮素、山柰黄素糖苷。现代药理试验表明八角莲的鬼臼毒素对疱疹病毒具有显著的抑制作用,其中山柰酚对金黄色葡萄球菌、伤寒和绿脓杆菌等具有抑制作用。八角莲具有清热解毒,拔毒生肌、祛瘀止痛,化痰散结功能。
乳香 辛、苦、温,其中化学成分中的树脂含量高,树胶仅占27~35%,挥发油3~8%。树脂的主要成分为游离α,β-乳香脂酸,乳香树脂烃。树胶为阿糖酸的钙盐和镁盐,还有西黄芪胶粘素;此外尚含萜烯类挥发油。药理实验表面乳香具有调气活血、消肿生肌、促进疮疡愈合,有较显著止痛镇痛作用。同时,乳香可以促进白血球增加,能够吞噬将死亡的血球和细胞,以改善身体的新陈代谢,起到抗菌消炎的目的,常用于治疗疮疡溃破久不愈。
满山香辛、苦、温,满山香为五味子科五味子属植物,其化学成分含有三萜烯酸、联苯环辛二烯木脂素、五味子丙素和挥发油等,其中其挥发油的主要物质是水杨酸甲酯。药理作用显示满山香浓度75%水煎液对鸡胚内对亚甲型流感病毒具有显著抑制作用。可解热止痛、消炎杀菌、活血通络、祛风除湿,常用于治牙痛、跌扑肿痛、虫蛇咬伤,满山香根叶提取液的复方注射液可治疗肺癌。
丁香甘、辛、大热,其生物活性成分主要是挥发油,其挥发油含有丁香油酚、β-丁香烯、乙酰基丁香油酚等,另含丁香酚、乙酰丁香酚、异槲皮素、山柰酚、槲皮素、石竹烯氧化物、齐墩果酸、α-衣兰油烯等。丁香对多种致病性真菌、球菌、链球菌及肺炎、痢疾、大肠、伤寒等杆菌以及流感病毒有抑制作用。丁香有抗溃疡、镇痛、抗缺氧、抗凝血,抗突变、灭菌杀虫的功效与作用。
大茴香性温、辛,也称为八角茴香,属木兰科植物,成熟果实常用于调味香料。大茴香果实的化学成分有黄酮类物质、倍半萜内酯及其衍生物、苯丙烷类和木脂素类。八角茴香水煎剂对结核杆菌及枯草杆菌有抑制作用,其乙醇提取液对金黄色葡萄球菌、肺炎球菌、白喉杆菌、霍乱弧菌右寒杆菌、副伤寒杆菌、痢疾杆菌及一些常见病菌有较强的抑制作用。其能够温阳扶正、散热除湿、理气止痛、驱虫解毒等。
现代科学研究已经证实硒与一些皮肤病的发生、发展密切相关,皮肤病患者血清中硒含量明显降低正常人水平。而硒(Se)是人类和动物必需的营养元素,具有广泛的生物学功能,尤其在抗氧化、免疫调节、抗炎症、抗肿瘤、抗衰老等方面功能显赫。其可介入细胞新陈代谢,提高人体免疫活化,增强人体免疫功能,也是有机体重要的抗氧化酶谷胱甘肽过氧化物酶的必需组分。为此,在中药药效成分中提高硒元素的富积,不仅可保障针对病原体引起的皮肤病高效治疗,还通过外用药剂的皮肤吸收过程,提高皮肤病人营养元素硒,增强皮肤病人免疫功能,促进皮肤溃疡的快速愈合。据此,本发明人选定适量的富硒茶叶作为本发明所述原料药中富硒含量的中药组分。
综上所述,所述原料药的化学成分分析和药理试验等基础研究是本发明所述外用中药发酵液外用喷剂针对病毒性、细菌性和真菌性皮肤病进行速愈治疗的科学理论根据。本发明人通过反复的药性对比、皮肤病辩证和临床应用验证,厘定了本发明中应病而治的所述中药组合物中的原料药及其重量份数。
步骤二、微生物菌液的制备
按照微生物菌种和培养液重量比为1:10~1000的比例,将所述微生物菌种分散于培养液中,搅拌均匀后,20~42℃下振荡发酵1~7天后,制得微生物菌液,备用。
其中所述微生物菌种指的是光合菌、酵母菌、乳酸菌、放线菌、丝状菌、芽孢菌、双歧杆菌、固氮菌、硝化细菌、醋酸杆菌、钾细菌、磷细菌、硫磺菌或木霉菌中的一种或两种以上。
所述培养液指的是按照城市泔水和水重量比1:1~100比例,将城市泔水和水混合一起粉碎制浆,调整pH=4~6,控温80~100℃蒸煮3~30分钟,后经降温、沉降、过滤除渣、制得的。
本发明选择城市泔水作为所述微生物菌液的培养液,目的是为所述微生物种群提供品种丰富且完善的营养物,充分满足所述不同菌种群在培养液中的活化和扩培,并且城市泔水营养全面、价格低廉、来源广、取用方便。
步骤三、中药发酵液的制备
将步骤一所得中药浸取液或中药浸取浓缩液和步骤二所得微生物菌液按照重量比1:0.05~0.5的比例混合均匀,控温20~42℃振荡发酵0.2~500小时,后经过滤除渣,制得本发明所述速愈治疗皮肤病的外用中药发酵液,灌装喷雾瓶即是中药发酵液外用喷剂。
本发明人认为博落回和八角莲的毒性大,荜茇、丁香是大热中药组分,为了调和所述中药组合物的毒性、药性和药效,结合现代微生物工程技术,采取液体发酵方法,对步骤一中药浸取液或中药浸取浓缩液进行微生物菌种的发酵处理。对比实验结果表明,本发明所述中药发酵液的抗菌效能显著高于所述中药浸取液或其浓缩液。
本发明的目的是提供一种速愈治疗皮肤病的中药外用喷剂,其功效在于消疼止痒、消炎杀菌、噬菌清洁、清热解毒、活血生肌、增强免疫、促进愈合,对于病毒性、细菌性和真菌性皮肤病具有广泛的起效快、疗效高,痊愈率高,不易复发,病灶喷涂刺激小,无不良反应和毒副作用的特点。
本发明所述一种速愈治疗皮肤病的中药外用喷剂,可采用现代工业设备规范生产,工艺技术简单,携带存放方便,使用简单安全。
具体实施方式
实施例1
步骤一、依次称取博落回12克、黄蜀葵12克、荜茇12克、八角莲12克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶40克,后一起混合研磨粉碎,过20目筛,制得中药组合物粉末,混入360克乙醇体积分数为93%的乙醇水溶液中,在25℃下浸泡48小时,滤除中药残渣,制得中药浸取液(1),备用;或将中药浸取液(1)经负压蒸馏浓缩至1/2体积,成中药浸取浓缩液(1),备用。
步骤二、称取城市泔水18克,混入106克自来水中,使用制浆机进行粉碎制浆,后置入蒸锅中,搅拌蒸煮3分钟,取出降温、过滤去除残渣,制得培养液;其后在所得培养液中加入5克微生物菌种搅匀,后控温37℃振荡发酵2天,制得微生物菌液,备用。
其中微生物菌种指的是包括光合菌、酵母菌、乳酸菌、放线菌、丝状菌、芽孢菌、双歧杆菌、固氮菌、硝化细菌、醋酸杆菌、钾细菌、磷细菌、硫磺菌、木霉菌的复合菌剂。
步骤三、分别称取步骤一制得的中药浸取液(1)300克和步骤二制得的微生物菌液100克,混合均匀后,置于培养罐中,控温37℃附近,常态下进行振荡发酵24小时,此后过滤去除残渣,制得中药发酵液(1)。将中药发酵液(1)分别罐装200mL、100mL或60mL消毒后的聚乙烯喷剂瓶,即得一种治疗皮肤病速愈的外用中药发酵液喷剂。经化学分析实施例1的中药发酵液(1),其中固形物重量含量13.22%,乙醇重量含量69.33%,含水重量17.45%。
或将中药浸取液(1)300克改换为中药浸取浓缩液(1)300克,制得中药发酵浓缩液(1)。经化学分析实施例1的中药发酵浓缩液(1),其中固形物重量含量24.07%,
乙醇含量56.80%,含水量19.13%。
实施例2
称取博落回6克、黄蜀葵6克、荜茇12克、八角莲12克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶叶20克;依照实施例1的方法和操作,即制得所述中药浸取液(2)和中药发酵液(2)外用喷剂。经化学分析实施例2的中药发酵液(2),其中固形物质含量11.07%,乙醇含量68.76%,含水量20.17%。
实施例3
称取博落回12克、黄蜀葵12克、荜茇6克、八角莲6克、乳香2克、丁香2克、满山香4克、大茴香4克和富硒茶叶20克;依照实施例1的方法和操作,步骤一中的乙醇体积分数93%的乙醇水溶液改换为乙醇体积分数75%的乙醇水溶液,
制得中药浸取液(3),步骤三中的所述微生物菌液100克改换为微生物菌液80克,即制得中药发酵液(3)外用喷剂。经化学分析实施例1的中药发酵液(3),其中固形物质含量12.56%,乙醇含量59.03%,含水量28.41%。
实施例 4
称取博落回12克、黄蜀葵12克、荜茇8克、八角莲8克、乳香6克、丁香4克、满山香8克、大茴香4克和富硒茶叶40克。依照实施例1的方法和操作,实施例1步骤一中的乙醇体积分数93%的乙醇水溶液改换为乙醇体积分数75%的乙醇水溶液,制得中药浸取液(4);步骤三中的所述微生物菌液100克改换为微生物菌液50克,即制得中药发酵液(4)外用喷剂。经化学分析实施例4中药发酵液(4),其中固形物质量含量15.12%,乙醇质量含量64.09%,含水量20.79%。
或将中药浸取液(4) 负压蒸馏浓缩至1/2体积,制得中药浸取浓缩液(2) ,再经与微生物菌液50克混合发酵后,制得中药发酵浓缩液(2)外用喷剂。经化学分析中药发酵浓缩液(2),其中固形物质含量27.68%,乙醇含量50.78%,含水量21.54%。
分别依照GB 5749-2006、GB/T 5750.12-2006、GB/T 7475-1987、GB/T 7466-1987、GB/T 7467-1987、GB/T 11912-1989、GB/T 11911-1989、GB 8978-1996、GB/T 11907-1989的程序和方法,对实施例1~4所述的中药发酵液或中药发酵浓缩液进行送样检测。经相关专业质量检测机构的分析检测,在实施例1~4所述中药发酵液(1)~(4)或中药发酵浓缩液中均未检出诸如金黄色葡萄球菌或大肠杆菌等致病菌,诸如砷、汞、镉、铬、铅等重金属分析检测含量均符合国家相关标准。
实施例5 中药发酵液的生物试验
1、抑菌试验:将已灭菌的水琼脂10mL融化后,趁热倒入9cm直径的培养皿
中,待水琼脂凝固;将已融化的10mL沙氏培养基冷至约45~50℃,迅速吸取1mL菌浓度为1.5×108CFU/mL菌液加入培养基内,充分混匀后,倒入已凝固的水琼脂上,
待充分凝固;用灭菌的打孔器在每个琼脂平板上打3个孔,孔中分别加入40μL相同药液浓度的实施例1~4的中药发酵液或中药浸取液;每种菌液对应每个试样品各制作3个含菌琼脂平板,置37℃培养箱中培养24小时;使用卡尺测量抑菌圈取平均值,试验结果见表1。
表1 中药发酵液的抑菌试验
表1中的结果表明实施例1~4的中药发酵液和中药浸取液对金黄色葡萄球菌和大肠杆菌均有显著的抑菌功能,并且通过发酵过程的中药发酵液抑菌效果均高未于经发酵处理的中药浸取液,说明本发明采用混合菌种对所述中药组合物的乙醇水溶液浸取液进行发酵处理,对于提高其治疗皮肤病的效果具有积极意义。其次,抑菌试验结果表明所述中药发酵液和中药发酵浓缩液中的中药有效成分增高,抑菌效果增强,这对于皮肤病的辨证辨病用药治疗提供了实验依据。
2、药效试验:使用中药发酵液(1)试验小鼠醋酸扭体实验,结果发现中药发酵液(1)能明显降低醋酸致小鼠扭体次数,能够缩短小鼠因甲醛伤害舔咬后足及阴器的时间;在磷酸组胺所致豚鼠皮肤瘙痒的实验中,观察到中药发酵液(1)小剂量、中剂量和高剂量均能提高组胺所致豚鼠的致痒阈,还能改善二甲苯致小鼠耳廓肿胀的作用。以上药效试验结果提示本发明所述中药发酵液具有明显镇痛、止痒和抗炎作用。
3、毒性和刺激性试验:使用本发明所述中药发酵液(1)和中药发酵浓缩液(1)连续两周涂擦家兔的完整皮肤及破损皮肤,均无急性毒性反应,也没有表现出刺激作用;同时皮肤过敏试验表明中,使用所述中药发酵液(1)重复涂擦豚鼠,未见豚鼠皮肤过敏反应。以上均表明本发明所述中药发酵液的皮肤外用均无刺激、无过敏现象,使用安全。
经临床诊断后,应用本发明所述中药发酵液(1)~(4)外用喷剂或中药发酵浓缩液外用喷剂,收集治疗多种皮肤病征患者74例,其中带状疱疹、湿疹和风疹17例,治愈17例;脚气21例,治愈20例,显效1例;痤疮33例,治愈30例,显效3例;糖尿病足3例,治愈3例。以下是应用本发明所述中药发酵液治疗皮肤病速愈的典型病例:
病例1:董某,男,65岁,患者病前无明显诱因出现右侧胸胁部疼痛,程度轻微,有时刺痛,未予特殊重视。过后患者右侧胸胁部出现呈带状分布、簇集性水泡,表现为针刺样疼痛,且情绪烦躁,遂诊、诊断为带状疱疹,遵医嘱口服阿昔洛韦三天,见轻未愈;后改用中药发酵液(1)喷剂喷涂患处,治疗10日后,患者右侧胁部疼痛消失,感觉正常,三个月后复诊未复发。
病例2:单某某,男,54岁,患者口述初期腰部出现泡疹,比较痒,手抓后局部出现腐烂化脓,衣物摩擦时疼痛更加难忍。经医院诊断为带状疱疹,大剂量注射抗生素并口服阿昔洛韦治疗,一周病情有所减轻。经人介绍转院使用中药发酵浓缩液(1)喷剂喷涂患处,每2~4小时喷涂一次,连续使用,皮损面积显著缩小,大部分疱疹结痂,7日后疱疹患处全部消失。半年后随访患者,原患处无感觉,无复发。
病例3:余某某,女,83岁,患者8天前后背有烧灼刺痛感,经查看已经出现簇集性水泡,夜里睡觉被褥摩擦疼痛难忍。诊断后遵医服用阿昔洛韦,并使用阿昔洛韦软膏未见好转。夜不能寐,难受的要死。亲属带其就诊后使用中药发酵液(1)喷剂喷涂患处,逐日见好,痒疼渐轻,治疗7日后,患者背部疼痛消失,感觉正常。
病例4:包某,女,28岁。几年前不明原因身体部位红斑丘疹伴瘙痒,以肘窝和腘窝明显,时轻时重。两天前加重,瘙痒剧烈,双眼睑肿胀,诊断为特应性皮炎,也叫四弯风。后经使用中药发酵液(2)喷剂进行外洗湿涂治疗,喷涂时有清凉感觉,约半小时后,瘙痒感觉明显缓解,连续使用7天后,复诊瘙痒症状消失,皮损面积较前较少,又10余天后病情基本痊愈。
病例5:甘某某,男,32岁,患有脚气,脚趾瘙痒、脚臭。观察到脚趾间皮肤浸渍发白,表面松软易剥脱后露出潮红糜烂面,诊断为糜烂性脚气,使用中药发酵液(3)喷剂喷涂双脚。口述每次喷涂时有一过性的刺疼,约10分钟后,瘙痒疼痛感明显减轻,每日喷涂6~8次,连续使用6日后,脚气治愈。
病例6:王某某,男,51岁,病人患糖尿病。因一次事故,左脚跟内侧被扎破,
久日未愈合,渐发展成坏疽情况。经医院诊断后使用中药发酵液(4)喷剂,每1~2小时涂抹一次,连续使用15日后,溃疡面积减小,20天后愈合。
病例7:张某某,女,59岁,糖尿病病患。有时走路坡脚未注意,洗浴时发现右脚发黑,随后就医,诊断为糖尿病并发症足病,属于干性坏疽,无并发感染,遵医嘱,用39~40℃温水泡脚半小时,擦干脚后多次喷涂中药发酵液(4)喷剂,连续使用一周后,右脚黑色褪去,渐恢复正常肤色。
病例8:程某某,女,62岁,糖尿病患者。右脚趾出现溃疡性坏疽,大脚趾坏死、趾甲脱落,并有脓性渗液渗出,其余四脚趾均有不同程度感染坏疽。经医院诊断为糖尿病并发症足趾坏疽,曾多方求医治疗。其家人告知转院喷涂中药发酵浓缩液(2)喷剂,待喷液干后,重复喷涂中药发酵液,尽可能保持溃疡部位湿润,连续11日后,右脚大脚趾溃疡面积明显缩小,其余四个脚趾坏疽已痊愈;又一周后大脚趾溃疡部位痊愈。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (6)
1.一种速愈治疗皮肤病的中药外用喷剂,其特征在于制备所述中药外用喷剂所用的原料药是按照重量组份组成的中药组合物,包括博落回6~12份、黄蜀葵6~12份、荜茇6~12份、八角莲6~12份、乳香2~12份、满山香2~8份、丁香2~8份、大茴香2~8份和富硒茶叶12~60份。
2.依照权利要求1所述一种速愈治疗皮肤病的中药外用喷剂,其特征在于所述皮肤病指的是由病原体引起的病毒性皮肤病、细菌性皮肤病或真菌性皮肤病。
3.依照权利要求1所述一种速愈治疗皮肤病的中药外用喷剂,其特征在于所述中药外用喷剂的具体制备方法包括如下步骤:
步骤一、中药浸取液的制备
按照所述原料药重量份数,称取后混合一起研磨粉碎,过20~80目筛,制得中药组合物粉末;按重量比为1:0.5~50的比例,将所述中药组合物粉末浸没于乙醇水溶液中,控温10~60℃浸泡1~7天后,过滤弃渣,制得中药浸取液,或经浓缩制得中药浸取浓缩液,备用;
其中所述原料药包括博落回6~12份、黄蜀葵6~12份、荜茇6~12份、八角莲6~12份、乳香2~12份、满山香2~8份、丁香2~8份、大茴香2~8份和富硒茶叶12~60份;
步骤二、微生物菌液的制备
按照微生物菌种和培养液重量比为1:10~1000的比例,将所述微生物菌种分散于培养液中,搅拌均匀后,20~42℃下振荡发酵1~7天后,制得微生物菌液,备用;
步骤三、中药发酵液的制备
将步骤一的中药浸取液或中药浸取浓缩液和步骤二的微生物菌液按照重量1:0.05~0.5比例混合均匀,控温20~42℃振荡发酵0.2~500小时,后经过滤除渣,制得中药发酵液,灌装喷雾瓶即成为所述治疗皮肤病速愈的中药外用喷剂。
4.依照权利要求2所述一种速愈治疗皮肤病的中药外用喷剂,其特征在于所述乙醇水溶液指的是乙醇体积分数为50~95%的乙醇水溶液。
5.依照权利要求2所述一种速愈治疗皮肤病的中药外用喷剂,其特征在于所述微生物菌种指的是光合菌、酵母菌、乳酸菌、放线菌、丝状菌、芽孢菌、双歧杆菌、固氮菌、硝化细菌、醋酸杆菌、钾细菌、磷细菌、硫磺菌或木霉菌中的一种或两种以上。
6.依照权利要求2所述一种速愈治疗皮肤病的中药外用喷剂,其特征在于所述培养液是按照城市泔水和水重量比1:1~100比例,将城市泔水和水混合一起粉碎制浆,调整pH=4~6,控温80~100℃蒸煮3~30分钟,后经降温、沉降、过滤除渣、制得的。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310014845.5A CN115814001A (zh) | 2023-01-06 | 2023-01-06 | 一种速愈治疗皮肤病的中药外用喷剂 |
CN202311754336.2A CN117797217A (zh) | 2023-01-06 | 2023-12-20 | 一种速愈治疗皮肤病的中药外用喷剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310014845.5A CN115814001A (zh) | 2023-01-06 | 2023-01-06 | 一种速愈治疗皮肤病的中药外用喷剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115814001A true CN115814001A (zh) | 2023-03-21 |
Family
ID=85520159
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310014845.5A Pending CN115814001A (zh) | 2023-01-06 | 2023-01-06 | 一种速愈治疗皮肤病的中药外用喷剂 |
CN202311754336.2A Pending CN117797217A (zh) | 2023-01-06 | 2023-12-20 | 一种速愈治疗皮肤病的中药外用喷剂 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311754336.2A Pending CN117797217A (zh) | 2023-01-06 | 2023-12-20 | 一种速愈治疗皮肤病的中药外用喷剂 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN115814001A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111821414A (zh) * | 2020-07-22 | 2020-10-27 | 焦作赛科中药生物科技有限公司 | 一种中药止痒喷剂及其制备方法 |
-
2023
- 2023-01-06 CN CN202310014845.5A patent/CN115814001A/zh active Pending
- 2023-12-20 CN CN202311754336.2A patent/CN117797217A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111821414A (zh) * | 2020-07-22 | 2020-10-27 | 焦作赛科中药生物科技有限公司 | 一种中药止痒喷剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN117797217A (zh) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110868B (zh) | 一种皮肤护理液及其制备方法 | |
CN111097040A (zh) | 抗病毒清肺肽 | |
CN104739925A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
CN111297961A (zh) | 一种促进伤口愈合的侗药 | |
CN104208294B (zh) | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 | |
KR20220010980A (ko) | 대마 추출물을 유효성분으로 포함하는 항균 및 항바이러스 조성물 | |
CN108853277A (zh) | 一种用于针灸的中药消毒液 | |
CN107890486B (zh) | 一种中药外用消炎制剂及其制备方法和应用 | |
CN110339234A (zh) | 一种用于治疗神经性耳鸣的含有大麻二酚的组合物及其制备方法 | |
CN115814001A (zh) | 一种速愈治疗皮肤病的中药外用喷剂 | |
Xu et al. | Application of Atractylodes Macrocephala Koidz Extract in Methicillin-Resistant Staphylococcus Aureus | |
KR20200119771A (ko) | 천연물을 포함하는 항균비누 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN105079305A (zh) | 一种抗菌消炎外用中药复方凝胶剂及其制备方法 | |
CN114931214B (zh) | 一种改善听力损伤的中草药组合物及其制备方法与应用 | |
CN107233486A (zh) | 一种治疗咽炎的老盐柠檬组合物及其制备方法 | |
CN115844956A (zh) | 一种用于速愈治疗妇科炎症的中药发酵水凝胶 | |
CN113332365B (zh) | 一种复方紫草膏及其制备方法 | |
CN118593566B (zh) | 一种含莲梗提取物的活血化瘀复合物及其制备方法 | |
CN116036149A (zh) | 纳米级小分子果核酸酯复合抑菌凝胶的制备方法及其应用 | |
CN118021870A (zh) | 一种中药组合物抑菌消炎祛痘凝胶及制备方法和应用 | |
CN107050298A (zh) | 一种治疗烧烫伤皮损的中药膏配方及制备方法 | |
CN105362675A (zh) | 一种治疗粉刺性乳痈的乳膏及其制备方法 | |
CN115154571A (zh) | 一种抗菌组合物及其应用 | |
CN105983035A (zh) | 一种治疗溃疡性创口的中药粉雾剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230321 |
|
WD01 | Invention patent application deemed withdrawn after publication |